Literature DB >> 32220335

Polypharmacological Perturbation of the 14-3-3 Adaptor Protein Interactome Stimulates Neurite Outgrowth.

Andrew Kaplan1, Sebastian A Andrei2, Anna van Regteren Altena3, Tristan Simas3, Sara L Banerjee4, Nobuo Kato5, Nicolas Bisson4, Yusuke Higuchi5, Christian Ottmann6, Alyson E Fournier7.   

Abstract

Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of phosphoprotein-binding molecules with critical functions in dozens of cell signaling networks. 14-3-3s are abundant in the central nervous system, and the small molecule fusicoccin-A (FC-A), a tool compound that can be used to manipulate 14-3-3 PPIs, enhances neurite outgrowth in cultured neurons. New semisynthetic FC-A derivatives with improved binding affinity for 14-3-3 complexes have recently been developed. Here, we use a series of screens that identify these compounds as potent inducers of neurite outgrowth through a polypharmacological mechanism. Using proteomics and X-ray crystallography, we discover that these compounds extensively regulate the 14-3-3 interactome by stabilizing specific PPIs, while disrupting others. These results provide new insights into the development of drugs to target 14-3-3 PPIs, a potential therapeutic strategy for CNS diseases.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  14-3-3; Rap1; axon; polypharmacology; regeneration; spinal cord injury

Mesh:

Substances:

Year:  2020        PMID: 32220335     DOI: 10.1016/j.chembiol.2020.02.010

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  8 in total

1.  007 (x2)-3-3: 14-3-3 Targeted Compounds as Double Agents.

Authors:  Mary Gannon; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2020-05-10       Impact factor: 14.819

Review 2.  Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein-Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases.

Authors:  Fengzhi Li; Ieman A M Aljahdali; Xiang Ling
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

Review 3.  14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases.

Authors:  F Sanders Pair; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2021-01-28       Impact factor: 14.819

4.  Targeting the Surface of the Protein 14-3-3 by Ultrasmall (1.5 nm) Gold Nanoparticles Carrying the Specific Peptide CRaf.

Authors:  Tatjana Ruks; Kateryna Loza; Marc Heggen; Christian Ottmann; Peter Bayer; Christine Beuck; Matthias Epple
Journal:  Chembiochem       Date:  2021-01-28       Impact factor: 3.164

5.  Hierarchized phosphotarget binding by the seven human 14-3-3 isoforms.

Authors:  Gergo Gogl; Kristina V Tugaeva; Pascal Eberling; Camille Kostmann; Gilles Trave; Nikolai N Sluchanko
Journal:  Nat Commun       Date:  2021-03-15       Impact factor: 14.919

6.  Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products.

Authors:  Madita Wolter; Pim de Vink; João Filipe Neves; Sonja Srdanović; Yusuke Higuchi; Nobuo Kato; Andrew Wilson; Isabelle Landrieu; Luc Brunsveld; Christian Ottmann
Journal:  J Am Chem Soc       Date:  2020-06-23       Impact factor: 15.419

7.  Characterization of a new fusicoccane-type diterpene synthase and an associated P450 enzyme.

Authors:  Jia-Hua Huang; Jian-Ming Lv; Liang-Yan Xiao; Qian Xu; Fu-Long Lin; Gao-Qian Wang; Guo-Dong Chen; Sheng-Ying Qin; Dan Hu; Hao Gao
Journal:  Beilstein J Org Chem       Date:  2022-10-05       Impact factor: 2.544

Review 8.  The Surprising Story of Fusicoccin: A Wilt-Inducing Phytotoxin, a Tool in Plant Physiology and a 14-3-3-Targeted Drug.

Authors:  Mauro Marra; Lorenzo Camoni; Sabina Visconti; Anna Fiorillo; Antonio Evidente
Journal:  Biomolecules       Date:  2021-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.